Cargando…
Safety and pharmacokinetics of bimagrumab in healthy older and obese adults with body composition changes in the older cohort
BACKGROUND: Bimagrumab prevents activity of myostatin and other negative regulators of skeletal muscle mass. This randomized double‐blind, placebo‐controlled study investigated safety, pharmacokinetics (PK), and pharmacodynamics of bimagrumab in healthy older and obese adults. METHODS: A cohort of o...
Autores principales: | Rooks, Daniel, Petricoul, Olivier, Praestgaard, Jens, Bartlett, Michael, Laurent, Didier, Roubenoff, Ronenn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749589/ https://www.ncbi.nlm.nih.gov/pubmed/33264516 http://dx.doi.org/10.1002/jcsm.12639 |
Ejemplares similares
-
Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity: A Phase 2 Randomized Clinical Trial
por: Heymsfield, Steven B., et al.
Publicado: (2021) -
Effect of bimagrumab on thigh muscle volume and composition in men with casting‐induced atrophy
por: Rooks, Daniel S., et al.
Publicado: (2017) -
Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults: A Randomized Clinical Trial
por: Rooks, Daniel, et al.
Publicado: (2020) -
Rheumatoid cachexia: a complication of rheumatoid arthritis moves into the 21st century
por: Roubenoff, Ronenn
Publicado: (2009) -
Strength training improves muscle quality and insulin sensitivity in Hispanic older adults with type 2 diabetes
por: Brooks, Naomi, et al.
Publicado: (2006)